What is this event about?

This is SMi's fifth conference on the subject of RNAi, siRNA and miRNA.  It will build on the success of the past four years, and brings together the leading experts in industry and academia to explore the cutting edge of new therapeutics being researched and brought to the marketplace. Taking place in London, UK, this conference will look at a wide range of issues within the RNAi arena.  It will combine a study of the latest successes in the research and development phase with presentations covering the key themes of delivery, target identification  and IP issues. Questions examined during the conference will include: What are the best delivery methods for siRNA and RNA-based therapeutics?  How do you carry out gene silencing?  What is the best method to use an siRNA library for target identification?  How is cell stress related to decreased RNAi?  What are the patent issues for oligonucleotides?  How do miRNAs regulate gene expression?   Fancy speaking at the conference?  Do you know of anyone who may be interested in speaking?  We are always on the look-out for new speakers for our upcoming conferences.  Let us know: smiproduction@smi-online.co.uk. For sponsorship and exhibitioning opportunities, contact sponsorshipdept@smi-online.co.uk

 Why should you attend this event?

Delegates at this conference will learn about The latest successes and failures for new targets and drugs Intellectual Property issues for RNA-based therapeutics Delivery technologies for siRNA and oligoneucleotides Nanomedicinal appraoches Development challenges for RNA-based therapeutics Immunology of nucleic acids
	How you will benefit from attending this conference Hear from some of the most important and influential experts working in RNAi Learn about the challenges faced by the industry in bringing RNAi therapeutics to the marketplace Study the latest targets and compounds being researched Network with people you need to know in the RNAi world

Who is chairing this event?

Who is speaking at this event?

Our keynote speakers Michael Keller Senior Fellow, siRNA Project Leader, Technical Research and Development(TRD) Novartis Ken Clark Director, Respiratory siRNA DPU GlaxoSmithKline Herbert Müller-Hartmann Director, R&D Lonza Peter Jackson Chief Operating Officer Medesis Pharma Marion Jurk Director, Discovery & Development Pfizer Oligonucleotide Therapeutics Unit (Düsseldorf)

Our expert speakers Aimee Jackson, Director of Drug Discovery, Regulus Therapeutics Dmitry Samarsky, VP, Technology Development, RXi Pharmaceuticals Claude Paul Malvy, Director, IFSBM, Universite Paris-Sud Mark Eccleston, Director, Business Development, ValiRx Jesper Wengel, Professor, Nucleic Acid Centre, University of Southern Denmark Suzy Lena Wengel, CEO, RiboTask Victoria González, Preclinical Manager, Sylentis (Zeltia Group) Georg Sczakiel, Professor, Institute for Molecular Medicine, Lubeck University Roberto Guerciolini, Senior Vice President, Dicerna Pharmaceuticals Lorna Brazell, Partner, Bird & Bird Elena Bichenkova, Senior Lecturer in Medicinal Chemistry, University of Manchester Karl-Hermann Schlingensiepen, CEO, Antisense Pharma Dimitris Lagos, Group Member, Cancer Research UK Viral Oncology Group Maurizio Ceppi, Project Manager, Genomic Vision Elena Vigorito, Group Leader, Lymphocyte Signalling & Development, Babraham Institute Marc Lemaitre, CEO, Girindus America Marie-Andree Yessine, Scientist, OctoPlus Development

Who should attend this event?

Chief Executives, Vice Presidents, Heads, Directors, Chief Scientists and Project Leaders of RNAi miRNA/microRNA siRNA RNA Silencing Genomics Technologies Bioinformatics Gene Modulation Chemistry and Manufacture Translational Research Discovery Chemistry Molecular Medicine Molecular Discovery Research Molecular Biology and Chemistry Regulatory Affairs Business Development

Delegates at our 2009 RNAi, siRNA and miRNA conference came from across the world

 Where is the event being held? 

Crowne Plaza London - The City The Crowne Plaza London - The City is a modern and stylish central London hotel in the heart of the City of London.  This deluxe hotel is just a step from Blackfriars Mainline Train Station which has a direct connection to St. Pancras International Eurostar Terminal. The hotel is a short walk from either Temple or Mansion House tube stations on the District & Circle lines or from St Paul's tube station on the Central Line.  Blackfriars tube station is currently closed due to the extensive renovation works taking place as part of the new Crossrail project. Crowne Plaza London - The City is ideally located for business and leisure, minutes away from some of London's most famous attractions: The London Eye, St Paul's Cathedral, the Millennium Bridge, Tate Modern and West End theatres. Crowne Plaza Club rooms, King Studios and Suites are available at your request. High Speed Internet access is offered in all fully air-conditioned bedrooms. Indulge at one of the hotel's three restaurants or bar.  Our acclaimed award winning Refettorio restaurant, directed by Michelin starred Chef Giorgio Locatelli, is the place to be seen in the city.  A sensational asian alternative is the newly opened Chinese Cricket Club.  For those seeking fitness and relaxation, our Fitness Club with sauna is complimentary to all hotel guests.

19 New Bridge Street  EC4V 6DB

Tel: +44 (0) 870 4009 190    Fax: +44 (0) 207 4388 080

Book your accommodation at SMi discounted rates by calling us on +44 (0)870 9090 713, sending a fax to +44 (0)870 9090 714 or emailing hotels@smi-online.co.uk.